HKD7.89
3.19% today
Hong Kong, Jul 07, 10:08 am CET
ISIN
HK1093012172
Symbol
1093
Index
Sector
Industry

CSPC Pharmaceutical Group Limited Stock price

HKD8.15
+0.10 1.24% 1M
+3.59 78.73% 6M
+3.37 70.50% YTD
+2.00 32.52% 1Y
+0.04 0.49% 3Y
-1.28 13.53% 5Y
+4.39 116.73% 10Y
+7.29 848.34% 20Y
Hong Kong, Closing price Fri, Jul 04 2025
-0.09 1.09%
ISIN
HK1093012172
Symbol
1093
Index
Sector
Industry

Key metrics

Basic
Market capitalization
HKD94.8b
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
20.9 | 16.5
P/S
3.2 | 2.8
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
HKD0.30
Yield 1Y | 5Y
3.7% | 2.6%
Growth 1Y | 5Y
20.0% | 26.2%
Payout 1Y | 3Y
55.6% | 46.6%
Increased
10 Years
Financials (TTM | estimate)
Revenue
HKD29.6b | HKD34.3b
EBITDA
- | HKD9.0b
EBIT
HKD5.9b | HKD7.5b
Net Income
HKD4.6b | -
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
-16.5% | 7.9%
EBITDA
- | 17.7%
EBIT
-30.3%
Net Income
-30.8% | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
68.5%
EBITDA
- | 26.2%
EBIT
20.0%
Net
15.5% | -
Free Cash Flow
-
Financial Health
Equity Ratio
72.7%
Return on Equity
13.4%
ROCE
-
ROIC
-
Debt/Equity
-
More
EPS
HKD0.4
FCF per Share
-
Short interest
-
Employees
21k
Rev per Employee
HKD1.5m
Show more

Is CSPC Pharmaceutical Group Limited a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,967 stocks worldwide.

CSPC Pharmaceutical Group Limited Stock Analysis

Unlock Scores for Free

Analyst Opinions

31 Analysts have issued a CSPC Pharmaceutical Group Limited forecast:

21x Buy
68%
8x Hold
26%
2x Sell
6%

Analyst Opinions

31 Analysts have issued a CSPC Pharmaceutical Group Limited forecast:

Buy
68%
Hold
26%
Sell
6%

Financial data from CSPC Pharmaceutical Group Limited

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
29,624 29,624
16% 16%
100%
- Direct Costs 9,348 9,348
8% 8%
32%
20,276 20,276
20% 20%
68%
- Selling and Administrative Expenses 9,135 9,135
23% 23%
31%
- Research and Development Expense 5,832 5,832
7% 7%
20%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 5,928 5,928
30% 30%
20%
Net Profit 4,594 4,594
31% 31%
16%

In millions HKD.

Don't miss a Thing! We will send you all news about CSPC Pharmaceutical Group Limited directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Antibiotics, Vitamin C, Caffeine and Others. The company was founded on August 21, 1997 and is headquartered in Hong Kong.

Head office Hong Kong
CEO Cui Zhang
Employees 21,400
Founded 1997
Website www.cspc.com.hk

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today